Eli Lilly
See the following -
Antibiotic Resistance: How Industrial Agriculture Lies With Statistics
...The website of the Alliance, a coalition of corporations and trade associations that make up a who's who of industrial agriculture, says the organization wants "to engage in dialogue with consumers who have questions about how today's food is grown and raised." It appears, however, that the organization is more concerned with countering increasing awareness of the public health and environmental harms associated with industrialized agriculture...
- Login to post comments
Eli Lilly Offers Designers $75k To Redesign Clinical Trial Info For Patients
Eli Lilly opens Clinical Trial Visualization Redesign Challenge for designers & developers to make clinical trial information more patient-friendly. Read More »
- Login to post comments
Eli Lilly Officially Sues Canada For 'Lost Profits' Because Canada Rejected Eli Lilly's Patents
A few years ago, we noted that Eli Lilly was facing some hard times, in large part because it had focused its entire business model around getting patents, and many of those patents were expiring, and very few new ones were in the pipeline. Even so, it was still rather surprising earlier this year to see Eli Lilly claim that Canada owed it $100 million for undermining the company's "expected future profits" by rejecting an Eli Lilly patent. Read More »
- Login to post comments
How Data Brokers Make Money Off Your Medical Records
A growing number of companies specialize in gathering longitudinal information from hundreds of millions of hospitals' and doctors' records, as well as from prescription and insurance claims and laboratory tests. Pooling all these data turns them into a valuable commodity. Other businesses are willing to pay for the insights that they can glean from such collections to guide their investments in the pharmaceutical industry, for example, or more precisely tailor an advertising campaign promoting a new drug...
- Login to post comments
Is the American Heart Association a Terrorist Organization?
A few days ago, the AHA stole the attention of headlines across the globe with a report that sounded like it was straight out of the 1990s: Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association. In this report, the AHA doubled down on their attacks against coconut oil and saturated fat. Frank Sacks, lead author on the report, reportedly said that he has no idea why people think coconut oil is healthy...
- Login to post comments
It’s About Time: Open APIs Finally Burst Onto Healthcare’s Sluggish Scene
In the midst of the struggles that we face with interoperability, efforts that support open API use may well hold the keys to the HIT Kingdom...
- Login to post comments
Strengthening Protection of Patient Medical Data
Americans seeking medical care expect a certain level of privacy. Indeed, the need for patient privacy is a principle dating back to antiquity, and is codified in U.S. law, most notably the Privacy Rule of the 1996 Health Insurance Portability and Accountability Act (HIPAA), which establishes standards that work toward protecting patient health information. But the world of information is rapidly changing, and in this environment, U.S. rules fall precariously short in protecting our medical data...
- Login to post comments
TPP Treaty Could be a Serious Threat to US Public Health System
While trade agreements may seem to be another, albeit international species of wonkery, these agreements could have major effects on patients' and the public's health. Since these concerns have been essentially ignored by the US medical and health care literature, (although they have appeared in UK journals, Australian, and New Zealand journals in English), they I will discuss them below. Worthy of further discussion is the possibility that these potential threats to health care and public health may arise not just from ideological disagreements, but also from health care corporations' increasing capture of government, facilitated by the conflicts of interest generated by the revolving door. Read More »
- Login to post comments
TransCelerate Shares Its Take On Risk-Based Monitoring Models And Tech
With clinical trial sponsors spending a sizable chunk of their huge Phase III trial budgets on source data verification (SDV) in return for questionable benefits, risk-based monitoring is an obvious target for TransCelerate BioPharma's R&D efficiency agenda. The Big Pharma consortium has further clarified its thinking on the topic in two research papers...
- Login to post comments
You Won't Believe the Outrageous Ways Big Pharma Has Bribed Doctors to Shill Drugs
At the 2010 meeting of the American Psychiatric Association in New Orleans, a psychiatrist from the East coast shared her anger with me about the recent clamp down on Pharma financial perks to doctors. Before news organizations and the 2010 Physician Financial Transparency Reports (also called the Sunshine Act, part of the Affordable Care Act) reported the outrageous amount of money Pharma was giving doctors to prescribe its new, brand-name drugs, there was almost no limit to what was spent to encourage prescribing...
- Login to post comments